medigraphic.com
SPANISH

Revista de Endocrinología y Nutrición

ISSN 0188-9796 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 4

Next >>

Rev Endocrinol Nutr 2011; 19 (4)

Vitamin D, obesity and insulin resistance: A not very loving triangle

Mendoza-Zubieta V, Reza-Albarrán A
Full text How to cite this article

Language: Spanish
References: 18
Page: 136-139
PDF size: 66.24 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-2072.

  2. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.

  3. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011; 364: 248-254.

  4. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in Adults: when to test and how to treat. Mayo Clin Proc 2010; 85: 752-758.

  5. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-687.

  6. IOM (Institute of Medicine). Dietary reference intakes for calcium and vitamin D. Washington DC: The National Academies Press

  7. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and Diabetes. Endocrinol Metab Clin North Am 2010; 39: 419-446.

  8. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64: 1165-1168.

  9. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesize vitamin D3. Lancet 1982; 1: 74-76.

  10. Osei K. 25-OH vitamin D: Is it the Universal Panacea for Metabolic Syndrome and Type 2 Diabetes. J Clin Endocrinol Metab 2010; 95: 4220-4222.

  11. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon MC, Hanley DA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.

  12. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.

  13. Cheng S, Massaro JM, Fox CS et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59: 242-248.

  14. Kenkt P, Laaksonen M, Mattila C et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008; 19: 666-671.

  15. Reis JP, von Mühlen D, Miller ER 3rd et al. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009; 124: e371-379.

  16. Loya-López GM, Godínez-Gutiérrez SA, Chiquete E, Valerdi-Contreras L, Taylor-Sánchez V. Niveles de vitamina D en pacientes con sobrepeso y obesidad y su asociación con resistencia a la insulina. Rev Endocr Nutr 2011; 19: 140-145.

  17. Pittas AG, Chung M, Trikalinos T et al. Syatematic review. Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.

  18. Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010; 121: 425-429.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Endocrinol Nutr. 2011;19